Related Experiment Video
Updated: Jun 11, 2026

Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model
Published on: October 10, 2017
VIP promotes resistance in the Pseudomonas aeruginosa-infected cornea by modulating adhesion molecule expression
Elizabeth A Berger1, Sharon A McClellan, Ronald P Barrett
1Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. eberger@med.wayne.edu
Purpose:
This study tested the hypothesis that the neuropeptide vasoactive intestinal peptide (VIP) regulates adhesion molecule expression, reduces inflammatory cell migration and infiltration into the Pseudomonas aeruginosa-infected cornea of susceptible B6 mice, and promotes corneal healing and resistance.
Methods:
B6 mice received daily intraperitoneal (IP) injections of VIP from -1 through 5 days after infection. Control mice were similarly injected with sterile phosphate-buffered saline (PBS). Transcript levels of adhesion molecules were determined by PCR array, then select molecules were tested individually by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) and confirmed at the protein level by enzyme-linked immunosorbent assay (ELISA) or immunofluorescent staining with confocal laser scanning microscopy at various time points after infection to assess the effects of VIP treatment in the regulation of adhesion molecule expression.
Results:
Injection of B6 mice with VIP compared with PBS resulted in significant downregulation of intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1, platelet-endothelial cell adhesion molecule-1, and P-selectin and L-selectin mRNA expression. Protein levels for ICAM-1 and VCAM-1, detected by ELISA, supported the mRNA data at similar time points. Immunofluorescence staining further confirmed the effects of VIP treatment, showing reduced corneal expression of ICAM-1/leukocyte function-associated antigen (LFA-1) and VCAM-1/very late antigen-4 (VLA-4) at select time points compared with PBS-treated animals.
Conclusions:
VIP treatment downregulates the production of adhesion molecules integral to the transmigration process of host inflammatory cells (polymorphonuclear neutrophils, macrophages) into the infected cornea. This results directly in reduced cellular infiltration, less stromal destruction, and better disease outcome.
Insights
Vasoactive intestinal peptide (VIP) treatment significantly reduced inflammatory cell infiltration in Pseudomonas aeruginosa-infected corneas by downregulating adhesion molecules, promoting corneal healing and resistance.
Area of Science:
- Ophthalmology
- Immunology
- Microbiology
Background:
- Bacterial keratitis, particularly Pseudomonas aeruginosa infections, can lead to significant corneal damage and vision loss.
- Inflammatory cell infiltration, mediated by adhesion molecules, plays a critical role in the pathogenesis of infectious keratitis.
- Neuropeptides are increasingly recognized for their immunomodulatory roles in various tissues, including the eye.
Purpose of the Study:
- To investigate the role of vasoactive intestinal peptide (VIP) in modulating the immune response during Pseudomonas aeruginosa keratitis.
- To determine if VIP affects adhesion molecule expression and inflammatory cell migration into the infected cornea.
- To assess the impact of VIP treatment on corneal healing and resistance to infection.
Main Methods:
- B6 mice were infected with Pseudomonas aeruginosa and treated with daily intraperitoneal injections of VIP or phosphate-buffered saline (PBS).
- Adhesion molecule expression was analyzed at the mRNA level using PCR arrays and real-time RT-PCR.
- Protein levels of key adhesion molecules were confirmed using ELISA and immunofluorescent staining.
Main Results:
- VIP treatment led to significant downregulation of mRNA for intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), P-selectin, and L-selectin.
- Protein analysis confirmed reduced levels of ICAM-1 and VCAM-1 in VIP-treated mice.
- Immunofluorescence demonstrated decreased corneal expression of ICAM-1/LFA-1 and VCAM-1/VLA-4 complexes.
Conclusions:
- VIP treatment effectively downregulates adhesion molecules crucial for inflammatory cell transmigration into the infected cornea.
- This reduction in adhesion molecule expression leads to decreased polymorphonuclear neutrophil and macrophage infiltration.
- VIP administration results in reduced corneal stromal destruction and improved disease outcomes in Pseudomonas aeruginosa keratitis.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Mechanism of Antibiotic Resistance in MRSA
Adherens Junctions
Adherens Junctions are Dynamic
The endothelial cells...
Clinical Significance of Antibiotic Resistance
